Author Topic: Non-approved (off-label) treatments used for MS disease modification  (Read 241 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
Cellcept (mycophonolate mofetil), Cladribine, Cytoxan (cyclophosphamide), Imuran (Azothioprine), Minocycline, Rituxan (rituximab), and statins are drugs that are prescribed off-label for MS.

The National MS Society lists them, with brief descriptions, and this list seems important enough to become a "sticky" thread, always near the top of the page:

"Non-approved treatments used for MS disease modification".
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
From PubMed (August 16, 2018) this abstract of an article by researchers at Beth Israel Deaconess Medical Center in Boston  has the title "Anti-JC virus antibody index changes in rituximab-treated MS patients":


https://www.ncbi.nlm.nih.gov/pubmed/30109480
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

 

Related Topics

  Subject / Started by Replies Last post
3 Replies
316 Views
Last post April 05, 2017, 11:15:40 am
by agate
1 Replies
250 Views
Last post June 29, 2018, 09:17:32 pm
by agate
0 Replies
137 Views
Last post July 26, 2018, 05:39:51 am
by agate
0 Replies
37 Views
Last post September 06, 2020, 03:58:52 pm
by agate
0 Replies
33 Views
Last post November 12, 2020, 09:40:31 pm
by agate